
Dr. Reddy's Laboratories Limited RDY
€ 11.40
-1.35%
Quartalsbericht 2022-Q1
hinzugefügt 27.06.2022
Dr. Reddy's Laboratories Limited Betriebszyklus 2011-2026 | RDY
Betriebszyklus Jährlich Dr. Reddy's Laboratories Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 279 | - | - | 167 | 150 | 148 | 155 | - | - | 170 |
Alle Zahlen in INR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 279 | 148 | 178 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alnylam Pharmaceuticals
ALNY
|
102 | $ 330.34 | 3.6 % | $ 43.3 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
130 | $ 0.44 | -16.64 % | $ 5.04 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
178 | $ 24.98 | 1.17 % | $ 3.05 B | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Cardiff Oncology
CRDF
|
294 | $ 1.58 | - | $ 106 M | ||
|
Curis
CRIS
|
103 | $ 0.53 | -3.07 % | $ 6.98 M | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Crinetics Pharmaceuticals
CRNX
|
554 | $ 37.7 | 1.26 % | $ 3.55 B | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 49.15 | -0.73 % | $ 4.42 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
CytomX Therapeutics
CTMX
|
12.2 | $ 4.4 | -3.51 % | $ 607 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Cue Biopharma
CUE
|
43.1 | $ 0.18 | -1.61 % | $ 17.1 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Aquestive Therapeutics
AQST
|
223 | $ 4.09 | -0.97 % | $ 437 M | ||
|
Cyclerion Therapeutics
CYCN
|
120 | $ 4.15 | -32.52 % | $ 10.4 M | ||
|
DBV Technologies S.A.
DBVT
|
71.3 | $ 20.36 | -3.32 % | $ 2.84 B | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 8.22 | 2.37 % | $ 225 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Denali Therapeutics
DNLI
|
1.89 | $ 19.38 | -6.15 % | $ 3.19 B | ||
|
Dyadic International
DYAI
|
78.4 | $ 0.87 | -2.8 % | $ 31.5 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
321 | $ 31.37 | 1.0 % | $ 2.08 B |